Report cover image

Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027

Publisher MarketLine
Published Oct 25, 2023
Length 315 Pages
SKU # MTLN18362563

Description

Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027


Summary

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).
  • All market data and forecasts are represented in nominal terms (i.e., without adjustment for inflation) and all currency conversions used in the creation of this report have been calculated using constant 2022 annual average exchange rates.
  • The global pharmaceuticals market had total revenues of $1,299.3 billion in 2022, representing a compound annual growth rate (CAGR) of 5.5% between 2017 and 2022.
  • The Asia-Pacific region acquired a 32.7% share of the global pharmaceuticals market in 2022. The growth in the global pharmaceuticals market is mainly due to the growth in emerging markets such as China and India. Emerging markets bring new opportunities to pharmaceutical companies.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts
Reasons to Buy
  • What was the size of the global pharmaceuticals market by value in 2022?
  • What will be the size of the global pharmaceuticals market in 2027?
  • What factors are affecting the strength of competition in the global pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the global pharmaceuticals market?

Table of Contents

315 Pages
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Competitive landscape
2 Introduction
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions
3 Global Pharmaceuticals
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in Asia-Pacific
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Pharmaceuticals in Europe
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
7 Macroeconomic Indicators
7.1. Country data
8 Pharmaceuticals in France
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis
9 Macroeconomic Indicators
9.1. Country data
10 Pharmaceuticals in Germany
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis
11 Macroeconomic Indicators
11.1. Country data
12 Pharmaceuticals in Italy
12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis
13 Macroeconomic Indicators
13.1. Country data
14 Pharmaceuticals in Japan
14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis
15 Macroeconomic Indicators
15.1. Country data
16 Pharmaceuticals in Australia
16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis
17 Macroeconomic Indicators
17.1. Country data
18 Pharmaceuticals in Canada
18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis
19 Macroeconomic Indicators
19.1. Country data
20 Pharmaceuticals in China
20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis
21 Macroeconomic Indicators
21.1. Country data
22 Pharmaceuticals in The Netherlands
22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis
23 Macroeconomic Indicators
23.1. Country data
24 Pharmaceuticals in Spain
24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis
25 Macroeconomic Indicators
25.1. Country data
26 Pharmaceuticals in The United Kingdom
26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis
27 Macroeconomic Indicators
27.1. Country data
28 Pharmaceuticals in The United States
28.1. Market Overview
28.2. Market Data
28.3. Market Segmentation
28.4. Market outlook
28.5. Five forces analysis
29 Macroeconomic Indicators
29.1. Country data
30 Company Profiles
30.1. Bayer AG
30.2. Novartis AG
30.3. Takeda Pharmaceutical Company Limited
30.4. Sanofi SA
30.5. Laboratoires Pierre Fabre SA
30.6. Les Laboratoires Servier
30.7. F. Hoffmann-La Roche Ltd
30.8. Boehringer Ingelheim GmbH
30.9. A Menarini Industrie Farmaceutiche Riunite Srl
30.10. Recordati S.p.A.
30.11. Chiesi Farmaceutici SpA
30.12. Daiichi Sankyo Co Ltd
30.13. Astellas Pharma Inc.
30.14. Mitsubishi Tanabe Pharma Corporation
30.15. Aspen Pharmacare Holdings Ltd
30.16. Apotex, Inc.
30.17. Yangtze River Pharmaceutical Group
30.18. Shanghai Pharmaceuticals Holding Co Ltd
30.19. Yunnan Baiyao Group Co Ltd
30.20. Guangzhou Pharmaceutical Holdings Ltd
30.21. Almirall S.A.
30.22. GSK plc.
30.23. Johnson & Johnson
30.24. Merck & Co., Inc.
30.25. Pfizer Inc.
30.26. AstraZeneca PLC
31 Appendix
31.1. Methodology
31.2. About MarketLine
List of Tables
Table 1: Global pharmaceuticals market value: $ billion, 2017-22
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Global pharmaceuticals market share: % share, by value, 2022
Table 4: Global pharmaceuticals market value forecast: $ billion, 2022–27
Table 5: Global size of population (million), 2018–22
Table 6: Global gdp (constant 2005 prices, $ billion), 2018–22
Table 7: Global gdp (current prices, $ billion), 2018–22
Table 8: Global inflation, 2018–22
Table 9: Global consumer price index (absolute), 2018–22
Table 10: Global exchange rate, 2018–22
Table 11: Asia-Pacific pharmaceuticals market value: $ billion, 2017-22
Table 12: Asia–Pacific pharmaceuticals market geography segmentation: $ billion, 2022
Table 13: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2022–27
Table 14: Europe pharmaceuticals market value: $ billion, 2017-22
Table 15: Europe pharmaceuticals market geography segmentation: $ billion, 2022
Table 16: Europe pharmaceuticals market value forecast: $ billion, 2022–27
Table 17: Europe size of population (million), 2018–22
Table 18: Europe gdp (constant 2005 prices, $ billion), 2018–22
Table 19: Europe gdp (current prices, $ billion), 2018–22
Table 20: Europe inflation, 2018–22
Table 21: Europe consumer price index (absolute), 2018–22
Table 22: Europe exchange rate, 2018–22
Table 23: France pharmaceuticals market value: $ billion, 2017-22
Table 24: France pharmaceuticals market geography segmentation: $ billion, 2022
Table 25: France pharmaceuticals market value forecast: $ billion, 2022–27
Table 26: France size of population (million), 2018–22
Table 27: France gdp (constant 2005 prices, $ billion), 2018–22
Table 28: France gdp (current prices, $ billion), 2018–22
Table 29: France inflation, 2018–22
Table 30: France consumer price index (absolute), 2018–22
Table 31: France exchange rate, 2018–22
Table 32: Germany pharmaceuticals market value: $ billion, 2017-22
Table 33: Germany pharmaceuticals market geography segmentation: $ billion, 2022
Table 34: Germany pharmaceuticals market value forecast: $ billion, 2022–27
Table 35: Germany size of population (million), 2018–22
Table 36: Germany gdp (constant 2005 prices, $ billion), 2018–22
Table 37: Germany gdp (current prices, $ billion), 2018–22
Table 38: Germany inflation, 2018–22
Table 39: Germany consumer price index (absolute), 2018–22
Table 40: Germany exchange rate, 2018–22
Table 41: Italy pharmaceuticals market value: $ billion, 2017-22
Table 42: Italy pharmaceuticals market geography segmentation: $ billion, 2022
Table 43: Italy pharmaceuticals market value forecast: $ billion, 2022–27
Table 44: Italy size of population (million), 2018–22
Table 45: Italy gdp (constant 2005 prices, $ billion), 2018–22
Table 46: Italy gdp (current prices, $ billion), 2018–22
Table 47: Italy inflation, 2018–22
Table 48: Italy consumer price index (absolute), 2018–22
Table 49: Italy exchange rate, 2018–22
Table 50: Japan pharmaceuticals market value: $ billion, 2017-22
Table 51: Japan pharmaceuticals market geography segmentation: $ billion, 2022
Table 52: Japan pharmaceuticals market value forecast: $ billion, 2022–27
Table 53: Japan size of population (million), 2018–22
Table 54: Japan gdp (constant 2005 prices, $ billion), 2018–22
Table 55: Japan gdp (current prices, $ billion), 2018–22
Table 56: Japan inflation, 2018–22
Table 57: Japan consumer price index (absolute), 2018–22
Table 58: Japan exchange rate, 2018–22
Table 59: Australia pharmaceuticals market value: $ billion, 2017-22
Table 60: Australia pharmaceuticals market geography segmentation: $ billion, 2022
Table 61: Australia pharmaceuticals market value forecast: $ billion, 2022–27
Table 62: Australia size of population (million), 2018–22
Table 63: Australia gdp (constant 2005 prices, $ billion), 2018–22
Table 64: Australia gdp (current prices, $ billion), 2018–22
Table 65: Australia inflation, 2018–22
Table 66: Australia consumer price index (absolute), 2018–22
Table 67: Australia exchange rate, 2018–22
Table 68: Canada pharmaceuticals market value: $ billion, 2017-22
Table 69: Canada pharmaceuticals market geography segmentation: $ billion, 2022
Table 70: Canada pharmaceuticals market value forecast: $ billion, 2022–27
Table 71: Canada size of population (million), 2018–22
Table 72: Canada gdp (constant 2005 prices, $ billion), 2018–22
Table 73: Canada gdp (current prices, $ billion), 2018–22
Table 74: Canada inflation, 2018–22
Table 75: Canada consumer price index (absolute), 2018–22
Table 76: Canada exchange rate, 2018–22
Table 77: China pharmaceuticals market value: $ billion, 2017-22
Table 78: China pharmaceuticals market geography segmentation: $ billion, 2022
Table 79: China pharmaceuticals market value forecast: $ billion, 2022–27
Table 80: China size of population (million), 2018–22
Table 81: China gdp (constant 2005 prices, $ billion), 2018–22
Table 82: China gdp (current prices, $ billion), 2018–22
Table 83: China inflation, 2018–22
Table 84: China consumer price index (absolute), 2018–22
Table 85: China exchange rate, 2018–22
Table 86: Netherlands pharmaceuticals market value: $ billion, 2017-22
Table 87: Netherlands pharmaceuticals market geography segmentation: $ billion, 2022
Table 88: Netherlands pharmaceuticals market value forecast: $ billion, 2022–27
Table 89: Netherlands size of population (million), 2018–22
Table 90: Netherlands gdp (constant 2005 prices, $ billion), 2018–22
Table 91: Netherlands gdp (current prices, $ billion), 2018–22
Table 92: Netherlands inflation, 2018–22
Table 93: Netherlands consumer price index (absolute), 2018–22
Table 94: Netherlands exchange rate, 2018–22
Table 95: Spain pharmaceuticals market value: $ billion, 2017-22
Table 96: Spain pharmaceuticals market geography segmentation: $ billion, 2022
Table 97: Spain pharmaceuticals market value forecast: $ billion, 2022–27
Table 98: Spain size of population (million), 2018–22
Table 99: Spain gdp (constant 2005 prices, $ billion), 2018–22
Table 100: Spain gdp (current prices, $ billion), 2018–22
Table 101: Spain inflation, 2018–22
Table 102: Spain consumer price index (absolute), 2018–22
Table 103: Spain exchange rate, 2018–22
Table 104: United Kingdom pharmaceuticals market value: $ billion, 2017-22
Table 105: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2022
List of Figures
Figure 1: Global pharmaceuticals market value: $ billion, 2017-22
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Global pharmaceuticals market share: % share, by value, 2022
Figure 4: Global pharmaceuticals market value forecast: $ billion, 2022–27
Figure 5: Forces driving competition in the global pharmaceuticals market, 2022
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2022
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2022
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2022
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2022
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2022
Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2017-22
Figure 12: Asia–Pacific pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 13: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2022–27
Figure 14: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2022
Figure 15: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2022
Figure 16: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2022
Figure 17: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2022
Figure 18: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2022
Figure 19: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2022
Figure 20: Europe pharmaceuticals market value: $ billion, 2017-22
Figure 21: Europe pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 22: Europe pharmaceuticals market value forecast: $ billion, 2022–27
Figure 23: Forces driving competition in the pharmaceuticals market in Europe, 2022
Figure 24: Drivers of buyer power in the pharmaceuticals market in Europe, 2022
Figure 25: Drivers of supplier power in the pharmaceuticals market in Europe, 2022
Figure 26: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2022
Figure 27: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2022
Figure 28: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2022
Figure 29: France pharmaceuticals market value: $ billion, 2017-22
Figure 30: France pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 31: France pharmaceuticals market value forecast: $ billion, 2022–27
Figure 32: Forces driving competition in the pharmaceuticals market in France, 2022
Figure 33: Drivers of buyer power in the pharmaceuticals market in France, 2022
Figure 34: Drivers of supplier power in the pharmaceuticals market in France, 2022
Figure 35: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2022
Figure 36: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2022
Figure 37: Drivers of degree of rivalry in the pharmaceuticals market in France, 2022
Figure 38: Germany pharmaceuticals market value: $ billion, 2017-22
Figure 39: Germany pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 40: Germany pharmaceuticals market value forecast: $ billion, 2022–27
Figure 41: Forces driving competition in the pharmaceuticals market in Germany, 2022
Figure 42: Drivers of buyer power in the pharmaceuticals market in Germany, 2022
Figure 43: Drivers of supplier power in the pharmaceuticals market in Germany, 2022
Figure 44: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2022
Figure 45: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2022
Figure 46: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2022
Figure 47: Italy pharmaceuticals market value: $ billion, 2017-22
Figure 48: Italy pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 49: Italy pharmaceuticals market value forecast: $ billion, 2022–27
Figure 50: Forces driving competition in the pharmaceuticals market in Italy, 2022
Figure 51: Drivers of buyer power in the pharmaceuticals market in Italy, 2022
Figure 52: Drivers of supplier power in the pharmaceuticals market in Italy, 2022
Figure 53: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2022
Figure 54: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2022
Figure 55: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2022
Figure 56: Japan pharmaceuticals market value: $ billion, 2017-22
Figure 57: Japan pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 58: Japan pharmaceuticals market value forecast: $ billion, 2022–27
Figure 59: Forces driving competition in the pharmaceuticals market in Japan, 2022
Figure 60: Drivers of buyer power in the pharmaceuticals market in Japan, 2022
Figure 61: Drivers of supplier power in the pharmaceuticals market in Japan, 2022
Figure 62: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2022
Figure 63: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2022
Figure 64: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2022
Figure 65: Australia pharmaceuticals market value: $ billion, 2017-22
Figure 66: Australia pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 67: Australia pharmaceuticals market value forecast: $ billion, 2022–27
Figure 68: Forces driving competition in the pharmaceuticals market in Australia, 2022
Figure 69: Drivers of buyer power in the pharmaceuticals market in Australia, 2022
Figure 70: Drivers of supplier power in the pharmaceuticals market in Australia, 2022
Figure 71: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2022
Figure 72: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2022
Figure 73: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2022
Figure 74: Canada pharmaceuticals market value: $ billion, 2017-22
Figure 75: Canada pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 76: Canada pharmaceuticals market value forecast: $ billion, 2022–27
Figure 77: Forces driving competition in the pharmaceuticals market in Canada, 2022
Figure 78: Drivers of buyer power in the pharmaceuticals market in Canada, 2022
Figure 79: Drivers of supplier power in the pharmaceuticals market in Canada, 2022
Figure 80: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2022
Figure 81: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2022
Figure 82: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2022
Figure 83: China pharmaceuticals market value: $ billion, 2017-22
Figure 84: China pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 85: China pharmaceuticals market value forecast: $ billion, 2022–27
Figure 86: Forces driving competition in the pharmaceuticals market in China, 2022
Figure 87: Drivers of buyer power in the pharmaceuticals market in China, 2022
Figure 88: Drivers of supplier power in the pharmaceuticals market in China, 2022
Figure 89: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2022
Figure 90: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2022
Figure 91: Drivers of degree of rivalry in the pharmaceuticals market in China, 2022
Figure 92: Netherlands pharmaceuticals market value: $ billion, 2017-22
Figure 93: Netherlands pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 94: Netherlands pharmaceuticals market value forecast: $ billion, 2022–27
Figure 95: Forces driving competition in the pharmaceuticals market in the Netherlands, 2022
Figure 96: Drivers of buyer power in the pharmaceuticals market in the Netherlands, 2022
Figure 97: Drivers of supplier power in the pharmaceuticals market in the Netherlands, 2022
Figure 98: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the Netherlands, 2022
Figure 99: Factors influencing the threat of substitutes in the pharmaceuticals market in the Netherlands, 2022
Figure 100: Drivers of degree of rivalry in the pharmaceuticals market in the Netherlands, 2022
Figure 101: Spain pharmaceuticals market value: $ billion, 2017-22

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us